FH is an elongated glycoprotein of 155 kDa composed of 20 SCRs (small circles). FH
presents C3b binding sites at each end of the molecule. The N-terminal C3b binding
site mediates the accelerated decay of the AP C3 convertase (C3bBb) and the
cofactor activity for the FI-dependent proteolytic inactivation of C3b. The
C-terminal region binds both C3b and polyanions normally present in the cell
surfaces (e.g., sialic acid, heparan sulfates, and glycosaminoglycans). This
region is essential for the complement regulatory activity of FH on surfaces and
to discriminate between self and pathogens, which normally lack these polyanions
on their surfaces. Extensive experimental data generated during the last 10 years
has provided conclusive evidence that mutations disrupting the functional activity
of the C-terminal region, like those associated with aHUS, decrease the avidity of
FH for cell surfaces and impair complement regulation (34–36). The
data reported here suggest similarities between the established model for the
aHUS-associated FH mutations and the FHR1 mutant described here. We therefore
propose that multimerization of the FHRs as a consequence of duplication of the
oligomerization domain in mutant FHR1, FHR2, or FHR5 proteins increases binding to
surface-bound C3b, iC3b, C3dg, and carbohydrates, resulting in enhanced
competition with FH that decreases its complement regulatory capacity and causes
different degrees of cell surface complement dysregulation.